» Articles » PMID: 19901968

A 'DNA Replication' Signature of Progression and Negative Outcome in Colorectal Cancer

Overview
Journal Oncogene
Date 2009 Nov 11
PMID 19901968
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer is one of the most frequent cancers worldwide. As the tumor-node-metastasis (TNM) staging classification does not allow to predict the survival of patients in many cases, additional prognostic factors are needed to better forecast their outcome. Genes involved in DNA replication may represent an underexplored source of such prognostic markers. Indeed, accidents during DNA replication can trigger 'replicative stress', one of the main features of cancer from earlier stages onward. In this study, we assessed the expression of 47 'DNA replication' genes in primary tumors and adjacent normal tissues from a homogeneous series of 74 patients. We found that genes coding for translesional (TLS) DNA polymerases, initiation of DNA replication, S-phase signaling and protection of replication forks were significantly deregulated in tumors. We also observed that the overexpression of either the MCM7 helicase or the TLS DNA polymerase POLQ (if also associated with a concomitant overexpression of firing genes) was significantly related to poor patient survival. Our data suggest the existence of a 'DNA replication signature' that might represent a source of new prognostic markers. Such a signature could help in understanding the molecular mechanisms underlying tumor progression in colorectal cancer patients.

Citing Articles

POLQ immunostaining behaves as a prognostic factor for pancreatic carcinoma.

Del Puerto-Nevado L, Fernandez-Acenero M, Cebrian A, Fatych Y, Diez-Valladares L, Perez-Aguirre E Front Oncol. 2024; 14:1433179.

PMID: 39435280 PMC: 11491332. DOI: 10.3389/fonc.2024.1433179.


From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies.

Gharib E, Robichaud G Int J Mol Sci. 2024; 25(17).

PMID: 39273409 PMC: 11395697. DOI: 10.3390/ijms25179463.


A non-tethering role for the Drosophila linker domain in promoting damage resolution.

Blanch J, Krishnamurthy M, McVey M bioRxiv. 2024; .

PMID: 39253446 PMC: 11383001. DOI: 10.1101/2024.08.27.609911.


Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors.

Bazan Russo T, Mujacic C, Di Giovanni E, Vitale M, Ferrante Bannera C, Randazzo U Cancer Gene Ther. 2024; 31(11):1619-1631.

PMID: 39122831 PMC: 11567890. DOI: 10.1038/s41417-024-00815-2.


New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives.

Previtali V, Bagnolini G, Ciamarone A, Ferrandi G, Rinaldi F, Myers S J Med Chem. 2024; 67(14):11488-11521.

PMID: 38955347 PMC: 11284803. DOI: 10.1021/acs.jmedchem.4c00113.